Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Paroxetine hydrochloride |
Is a |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Paroxetine poisoning (disorder) |
Causative agent (attribute) |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Accidental paroxetine poisoning |
Causative agent (attribute) |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Intentional paroxetine poisoning |
Causative agent (attribute) |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
intoxication par la paroxétine d'intention indéterminée |
Causative agent (attribute) |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Paroxetine adverse reaction |
Causative agent (attribute) |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Allergy to paroxetine (finding) |
Causative agent (attribute) |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Paroxetine overdose |
Causative agent (attribute) |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Accidental paroxetine overdose |
Causative agent (attribute) |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Intentional paroxetine overdose |
Causative agent (attribute) |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
surdose de paroxétine d'intention indéterminée |
Causative agent (attribute) |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing paroxetine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Product containing precisely paroxetine 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Paroxetine 10mg/5mL s/f liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Paroxetine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Oral form paroxetine m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Paroxetine 12.5mg tablet controlled-release |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Paroxetine 25mg tablet controlled-release |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Paroxetine 37.5mg tablet controlled-release |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Paroxetine mesylate 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Paroxetine mesylate 20mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Paroxetine mesylate 30mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Paroxetine mesylate 40mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Product containing precisely paroxetine 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Product containing precisely paroxetine 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Accidental paroxetine poisoning |
Causative agent (attribute) |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Intentional paroxetine poisoning |
Causative agent (attribute) |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Paroxetine mesilate |
Is a |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Product containing precisely paroxetine 10 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Product containing precisely paroxetine 40 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Allergy to paroxetine (finding) |
Causative agent (attribute) |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine 20 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine 30 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine 10 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine 10 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine 40 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine 40 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Paroxetine hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Paroxetine mesilate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
|
Product containing precisely paroxetine 10 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine 20 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine 30 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine 40 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine (as paroxetine hydrochloride) 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing only paroxetine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing only paroxetine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine (as paroxetine hydrochloride) 25 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine (as paroxetine hydrochloride) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine (as paroxetine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine (as paroxetine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Paroxetine (as paroxetine hydrochloride) 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Paroxetine (as paroxetine hydrochloride) 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Paroxetine (as paroxetine mesilate) 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Paroxetine (as paroxetine mesilate) 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine (as paroxetine mesilate) 20 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely paroxetine (as paroxetine mesilate) 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Paroxetine (substance) |
Inferred relationship |
Some |
1 |